Search

Author/Creator Lockhart, Catherine M.

1. Barriers and facilitators to conduct high‐quality, large‐scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience. Issue 7 (11th August 2019)

Authors:
Lockhart, Catherine M.; McDermott, Cara L.; Felix, Thomas; Lin, Nancy D.; Cziraky, Mark J.; Mendelsohn, Aaron B.; Brown, Jeffrey S.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 29:Issue 7(2020)
Page Start:
811
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Capture of biologic and biosimilar dispensings in a consortium of U.S.‐based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims. Issue 7 (4th December 2019)

Authors:
Zhang, Jie; Haynes, Kevin; Mendelsohn, Aaron B.; Marshall, James; Barr, Charles E.; McDermott, Cara; Brown, Jeffrey; Kline, Annemarie; Kenney, James; King, Katelyn J.; Holmes, Cynthia; Yeung, Kai; Barron, John; Yun, Huifeng; Lockhart, Catherine M.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 29:Issue 7(2020)
Page Start:
778
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm. (31st December 2023)

Authors:
Lockhart, Catherine M.; McDermott, Cara L.; Mendelsohn, Aaron B.; Marshall, James; McBride, Ali; Yee, Gary; Li, Minghui Sam; Jamal-Allial, Aziza; Djibo, Djeneba Audrey; Vazquez Benitez, Gabriela; DeFor, Terese A.; Pawloski, Pamala A.
Journal:
Journal of medical economics
Issue:
Volume 26:Number 1(2023)
Page Start:
403
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data. Issue 7 (18th December 2019)

Authors:
He, Mengdong; Santiago Ortiz, Adrian J.; Marshall, James; Mendelsohn, Aaron B.; Curtis, Jeffrey R.; Barr, Charles E.; Lockhart, Catherine M.; Kim, Seoyoung C.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 29:Issue 7(2020)
Page Start:
770
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars. Issue 7 (12th July 2019)

Authors:
Desai, Rishi J.; Kim, Seoyoung C.; Curtis, Jeffrey R.; Bosco, Jaclyn L.F.; Eichelberger, Bernadette; Barr, Charles E.; Lockhart, Catherine M.; Bradbury, Brian D.; Clewell, Jerry; Cohen, Hillel P.; Gagne, Joshua J.
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 29:Issue 7(2020)
Page Start:
757
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Utilization patterns and characteristics of users of biologic anti‐inflammatory agents in a large, US commercially insured population. Issue 1 (29th December 2020)

Authors:
Mendelsohn, Aaron B.; Nam, Young Hee; Marshall, James; McDermott, Cara L.; Kochar, Bharati; Kappelman, Michael D.; Brown, Jeffrey S.; Lockhart, Catherine M.
Journal:
Pharmacology research & perspectives
Issue:
Volume 9:Issue 1(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗